United States to help India's Biological E make 1 billion vaccine doses

The so-called Quad group agreed to expand efforts to ramp up vaccine manufacturing in the region

The U.S. International Development Finance Corp. will help fund Indian manufacturer Biological E Ltd.’s efforts to manufacture at least one billion doses of Covid-19 vaccines by the end of 2022.

The vaccines will be manufactured with “Stringent Regulatory Authorization and/or World Health Organization Emergency Use Listing, including Johnson & Johnson vaccines,” the U.S. agency said in a release Friday.

The announcement is part of the agency’s Global Health and Prosperity Initiative, under which it is working to increase manufacturing, production and distribution of vaccines, including Covid-19 vaccines.

The cooperation on boosting vaccine manufacturing capability was discussed by the leaders of the